학술논문
829P - Initial results from AQUARiUS, a prospective, observational, multi-centre phase IV study assessing patient-reported outcomes (PROs) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate plus prednisone (AAP) or enzalutamide (ENZ)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v287-v288
Subject
Language
ISSN
0923-7534